Clinical Trials · NCT01371643

Surgical Debulking of Pituitary Adenomas

CompletedPhase 4Octreotide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
NYU Langone Health
Enrollment
41
Start date
Apr 2004
Locations
1 site, United States
Primary endpoint
Percentage of Responders (Primary Medical Treatment in Arm 1, Primary Surgical Treatment in Arm 2)
View Octreotide compound reference